1. Home
  2. WVE vs NSSC Comparison

WVE vs NSSC Comparison

Compare WVE & NSSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • NSSC
  • Stock Information
  • Founded
  • WVE 2012
  • NSSC 1969
  • Country
  • WVE Singapore
  • NSSC United States
  • Employees
  • WVE N/A
  • NSSC N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • NSSC Telecommunications Equipment
  • Sector
  • WVE Health Care
  • NSSC Telecommunications
  • Exchange
  • WVE Nasdaq
  • NSSC Nasdaq
  • Market Cap
  • WVE 915.6M
  • NSSC 1.1B
  • IPO Year
  • WVE 2015
  • NSSC N/A
  • Fundamental
  • Price
  • WVE $7.79
  • NSSC $42.62
  • Analyst Decision
  • WVE Strong Buy
  • NSSC Strong Buy
  • Analyst Count
  • WVE 16
  • NSSC 6
  • Target Price
  • WVE $20.19
  • NSSC $40.33
  • AVG Volume (30 Days)
  • WVE 2.1M
  • NSSC 389.1K
  • Earning Date
  • WVE 11-11-2025
  • NSSC 11-03-2025
  • Dividend Yield
  • WVE N/A
  • NSSC 1.31%
  • EPS Growth
  • WVE N/A
  • NSSC N/A
  • EPS
  • WVE N/A
  • NSSC 1.19
  • Revenue
  • WVE $93,946,000.00
  • NSSC $181,621,000.00
  • Revenue This Year
  • WVE N/A
  • NSSC $11.30
  • Revenue Next Year
  • WVE $6.85
  • NSSC $8.78
  • P/E Ratio
  • WVE N/A
  • NSSC $35.80
  • Revenue Growth
  • WVE N/A
  • NSSC N/A
  • 52 Week Low
  • WVE $5.28
  • NSSC $19.00
  • 52 Week High
  • WVE $16.74
  • NSSC $45.03
  • Technical
  • Relative Strength Index (RSI)
  • WVE 52.90
  • NSSC 57.41
  • Support Level
  • WVE $6.91
  • NSSC $41.91
  • Resistance Level
  • WVE $8.31
  • NSSC $44.30
  • Average True Range (ATR)
  • WVE 0.42
  • NSSC 1.05
  • MACD
  • WVE 0.15
  • NSSC -0.40
  • Stochastic Oscillator
  • WVE 69.65
  • NSSC 22.90

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About NSSC NAPCO Security Technologies Inc.

NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: